SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure

Published: 31 August 2022

  • Views:

    Views Icon 51753

  • Likes:

    Heart Icon 7
  • episode_image
    12m 17s
    Part 5 Q&A and Discussion
    Scott Solomon, John JV McMurray, Carolyn Lam, Muthiah Vaduganathan
Average (ratings)
No ratings
Your rating

Overview

During this unique broadcast, ‘SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure’, Radcliffe Medical Education brings together a globally-renowned faculty to participate in a discussion centred around the presentation of the latest SGLT-2 inhibition data and how this translates to the treatment of Heart Failure patients.

 

Presented, and recorded, at ESC Congress 2022 in Barcelona, this programme is now available to watch on-demand. The programme is chaired by Prof Scott Solomon (Boston, US), who is joined by Prof John McMurray (Glasgow, UK), Prof Carolyn Lam (Singapore, SG) and Dr Muthiah Vaduganathan (Boston, US) while they explain how to assess the latest data for SGLT2 inhibitors in heart failure (HF) and how to apply it in real-world practice. 

 

This satellite symposium is supported by an unrestricted educational grant from AstraZeneca who had no involvement in the creation of the content.

 

 

CME accredited version available here
This satellite symposium is supported by an unrestricted educational grant from AstraZeneca who had no involvement in the creation of the content.

Learning Objectives

Upon participation in this programme, physicians will be able to:

  • Recall the results of key trials in HFmrEF in different patients' sub-groups
  • Describe how SGLT-2 inhibitors can be used across the range of LVEF
  • Apply emerging diagnostic approaches for HFpEF and HFmrEF
  • Implement best-practice strategies across the range of LVEF

This programme is intended to educate:

  • Global cardiologists
  • Heart Failure specialists
  • Primary care physicians
  • Nurses
  • Pharmacists

More from this programme

Part 1

SGLT2 Inhibitors - Another piece of the Puzzle in Heart Failure

1 session
SGLT2 Inhibitors: Light at the End of the Tunnel Watch now

Part 2

SGLT2 Inhibitors Across the Spectrum of Heart Failure

1 session
SGLT2 Inhibitors Across the Spectrum of Heart Failure Watch now

Part 3

Practical Considerations for Treating HF With Mildly Reduced and Preserved EP

1 session
Practical Considerations for Treating HF With Mildly Reduced and preserved EF Watch now

Part 4

Implementing Best Practices Across the Spectrum of Heart Failure

1 session
Implementing Best Practices Across the Spectrum of Heart Failure Watch now

Part 5

Q&A and Discussion

1 session
Q&A and Discussion Watch now

Faculty Biographies

John JV McMurray

John JV McMurray

Professor of Cardiology

Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.

Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.

View full profile